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Relevance
An estimated number of  240,000 people in the Netherlands are living with the consequences 
as a result of  a stroke (1). In 2014, stroke accounted for 21% of  all cardiovascular deaths, with 
a total number of  nearly 10.000 deaths (2). Yearly, approximately 44,000 people are admitted 
to a hospital due to a stroke (1). Additionally, the medical costs involved in the diagnosis and 
treatment of  stroke are substantial, accounting for 27.4% of  the costs involved in cardiovas-
cular care and 2.5% of  the total medical costs in the Netherlands (3). It is expected that these 
numbers will increase over the coming decades, mainly because of  the ageing population.
Hemorrhagic strokes account for approximately 10% of  all strokes, while the remaining 90% 
are ischemic strokes (4). A considerable amount (15-20%) of  ischemic strokes is caused by 
rupture of  an atherosclerotic plaque in the (internal) carotid artery (5). Currently, risk stra-
tification of  patients with a stenosis of  the carotid artery is based on the degree of  luminal 
stenosis and symptomatology of  the patient. Based on this, it is determined whether a carotid 
endarterectomy (CEA) is advised. Results from randomized trials have shown that CEA is 
beneficial for symptomatic patients with a carotid stenosis of  70-99% with a number needed 
to treat (NNT) of  6 to prevent one stroke in five years. However, for symptomatic patients 
with a stenosis of  50-69% CEA is only marginally effective with a NNT of  22 (6).
Histological studies on CEA specimens have shown that specific characteristics of  atheroscle-
rotic plaques have an increased incidence in symptomatic patients compared to asymptomatic 
patients (7-11). Features already identified as important hallmarks of  plaque vulnerability are 
a lipid-rich necrotic core (LRNC) with a thin/ruptured fibrous cap (TRFC), presence of  in-
flammatory cells, ulcerations, and intraplaque hemorrhage (IPH) (12). Additionally, it has been 
suggested that an increased microvasculature of  the atherosclerotic plaque is an important 
marker of  plaque vulnerability (13).
Identification of  these “vulnerable plaques” with non-invasive imaging of  the atherosclerotic 
vessel wall may provide opportunities for improved patient stratification. In particular patients 
with a mild to moderate stenosis may benefit from increased personalized treatment since for 
this patient population CEA is only marginally effective. Over the past years, technical impro-
vements of  non-invasive imaging methods have enabled in vivo visualization of  these vulne-
rable plaque characteristics.. Dynamic contrast-enhanced magnetic resonance imaging (DCE-
MRI) can be used to study and quantify the plaque microvasculature non-invasively (14).
The hypothesis of  the present thesis was that non-invasive imaging of  the plaque microvascu-
lature with DCE-MRI may provide further insight in the atherosclerotic process. An increased 
insight in the role of  the plaque microvasculature in the atherosclerotic process, may not only 
aid in identification of  patients at increased risk, but may also provide novel targets for thera-
peutic interventions in the prevention and stabilization of  atherosclerotic lesions.
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Valorisation
Target groups
The results of  this thesis are of  interest for a broad range of  professionals. First, it is of  in-
terest for scientists investigating the development of  atherosclerotic plaques. Results from 
the present thesis and previous studies show that plaque microvasculature is an important 
determinant of  atherosclerosis, since it is related to a number of  processes related to plaque 
destabilization. Pharmacokinetic modelling of  DCE-MRI data allows assessment of  plaque 
microvasculature in a non-invasive manner. Therefore, the plaque microvasculature can be 
investigated in animal models and patients at multiple time points during the various stages of  
plaque development, even before the onset of  clinical symptoms. This is of  great advantage 
compared to histopathological studies, in which investigation of  the plaque microvasculature 
can be performed only after euthanasia in animal studies and after CEA or at autopsy in pa-
tients. Non-invasive imaging of  the microvasculature using DCE-MRI can contribute to the 
reduction of  the amount of  animals used in research. 
Next to this, the results of  this thesis are of  interest for clinicians with a (research) interest in 
cerebrovascular disease. Currently, patients suffering from a recent ischemic cerebrovascular 
event undergo imaging of  the carotid arteries for determination of  the degree of  carotid 
stenosis. Based on the results, patients may be referred to vascular surgery for CEA. Ho-
wever, there is increasing evidence, from the present thesis and other research, that patient 
stratification may be improved by assessment of  the plaque components, including the plaque 
microvasculature. For further advancement of  carotid plaque imaging, longitudinal studies are 
needed to investigate the predictive value of  various plaque components, including plaque mi-
crovasculature for recurrent cerebrovascular events. For this purpose, the PARISk consortium 
in the Netherlands has performed longitudinal follow-up of  patients that have suffered from a 
recent cerebrovascular event with patient follow-up of  this trial finalized in December 2016, 
with results following in due time. The development of  plaque microvasculature in relation to 
recurrent cerebrovascular events will be studied in a subgroup of  these patients. After this 
prospective longitudinal study, it is important to investigate the potential value of  dedicated 
imaging of  carotid plaque microvasculature in a randomized surgery trial. Currently, imaging 
of  various other carotid plaque components is already included in the recently started large 
randomized European Carotid Surgery Trial-2.
In addition to clinicians with a research interest in cerebrovascular diseases, the present the-
sis is also of  general interest for clinicians. The results described in the present thesis may 
have impact on future guidelines for treatment of  patients with carotid atherosclerotic plaque. 
Currently, patients with a mild to moderate stenosis are generally not referred to a vascular 
surgeon for surgical removal of  the plaque, since randomized surgery trials performed in the 
early 90s of  the last century have shown that CEA is only marginally effective for them. These 
patients in particular may benefit from improved personalized treatment.
The present thesis is also of  interest for companies within the medical imaging industry. The 
results described in this thesis show the current state of  DCE-MRI of  the atherosclerotic 
plaque microvasculature. The development of  advanced MR imaging protocols and analysis 
methods for quantification of  the plaque microvasculature is expected to further advance 
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the clinical application of  DCE-MR imaging. Additionally, companies developing (pharmaco-
logical) treatments or interventions targeted to the atherosclerotic plaque microvasculature 
may express interest in the results described in this thesis. DCE-MRI enables the investigation 
of  the atherosclerotic plaque microvasculature non-invasively in animal models and patients. 
Compared to histopathological analysis, this enables evaluation of  the treatment effect at 
multiple time points in the same subject, even before the onset of  clinical symptoms. Thus, 
non-invasive imaging of  the microvasculature using DCE-MRI can contribute to the reduction 
of  the number of  subjects, either animals or volunteers, that are required to study potential 
new treatments and their effect on the plaque microvasculature.
Activities / products
In the present thesis, analysis of  the DCE-MRI data is performed using custom built software 
in Matlab (Natick, Mathworks, Massachusetts, United States). In addition, drawing of  the lu-
men and vessel wall contours is performed manually by an experienced observer using the 
Vesselmass software package (Leiden University Medical Center, Leiden, The Netherlands). 
This process may be suitable in a research environment, in which analysis is performed by 
experienced observers. However, this may be challenging in multicenter studies with analysis 
being performed by an increased number of  observers. Therefore, development of  a soft-
ware package in which the lumen and vessel wall contour drawing and data analysis can be 
performed (semi-)automatically is of  great interest. This software package is likely to be of  
added value for the potential success of  DCE-MRI in a research or future clinical setting with 
less experienced observers, which is needed for implementation of  the technique in a wider 
setting. On this topic, substantial progress has already been made based upon data from the 
PARISK consortium (15) and a spin-off company from the University of  Washington (16). 
However, main focus of  previous studies was the identification of  the various plaque compo-
nents on MR images while work on semi-automatic analysis tools for DCE-MR data has been 
limited. Extension of  this with methods to perform (non-rigid) transformations of  DCE-MRI 
data might be an important step in the development of  DCE-MRI software packages. These 
transformations may be useful to correct for (small) patient movements during the MR acqui-
sition, enabling improved (local) quantification of  the plaque microvasculature. Additionally, 
integration of  the developed methods into current software packages of  the major MR ven-
dors will be an important improvement in the availability of  these methods.
Innovation and Insights
Direct in vivo visualization of  the plaque microvasculature is complicated due to the small size 
of  the atherosclerotic plaque microvasculature (up to approximately 100 μm in diameter). 
However, pharmacokinetic modelling of  DCE-MRI allows voxelwise estimation of  microvas-
cular properties. In the present thesis several innovations are presented and applied to incre-
ase insights in the role of  the plaque microvasculature in atherosclerotic plaques.
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Valorisation
Firstly, a novel, method for determination of  the vascular input function (VIF) from phase MR 
images is described and applied for carotid DCE-MRI. The results from this thesis showed 
that VIFs derived from magnitude MR images were influenced by local blood flow velocity, 
leading to an underestimation of  the contrast medium concentration in the vessel lumen. In 
turn, absolute values of  determined pharmacokinetic parameters were influenced by the VIF, 
making direct cross-study comparisons of  different studies difficult. Additionally, the results of  
the present thesis showed that the absolute values of  the pharmacokinetic parameters deter-
mined may differ between different regions of  the vascular wall. Therefore, the results of  the 
present thesis clearly showed that the use of  a standard imaging and data analysis protocol is 
essential, in particular for longitudinal studies of  plaque microvasculature and for the future 
determination of  risk thresholds.
One study described in the present thesis aimed to confirm the potential positive association 
between the plaque microvasculature and the presence of  IPH, which has been suggested in 
previous research. However, the results of  this chapter showed a decreased microvascular 
flow, density, or leakiness of  the vessel wall in patients with IPH. Therefore, not only plaque 
microvasculature contributes to the development of  IPH in carotid atherosclerosis. Based 
on our results, it is likely that additional factors, such as a disrupted plaque surface, also play 
an important role and should be investigated in future studies to fully understand the pa-
thophysiology. Another important insight of  the present thesis is that patients with a recent 
ischemic stroke showed an increased microvascular flow, density, or leakiness of  the adventitia 
compared to patients with a recent transient ischemic attack (TIA) or ocular TIA (also known 
as amaurosis fugax). This association was independent of  clinical risk factors. The potential as-
sociation between plaque microvasculature and the type of  recent cerebrovascular event has 
to be further confirmed in a prospective longitudinal study, however this finding may provide 
additional information on the value of  DCE-MRI in the risk stratification of  patients.
Finally, the present thesis demonstrated the ability of  DCE-MRI as an evaluation tool for 
potential therapies in the treatment of  atherosclerosis. The results showed that heart-rate 
reducing therapy was associated with a reduction in vulnerable plaque features. Therefore, the 
results of  the present thesis added to current insights that plaque biomechanics and deforma-
tion may play an important role in the development of  vulnerable plaque features. Therefore, 
heart rate reduction may be a potential target for plaque stabilization. To investigate the po-
tential relationship between the plaque microvasculature and plaque biomechanics, including 
the underlying mechanisms, longitudinal studies incorporating both measurements should be 
performed in the future.
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